RASSF1 and neoplasm: Through genome-wide DNA methylation assays, Hsu et al. detected a multiple epigenetic panel in tumor samples by studying the methylation status of genes CDH13, BLU, FHIT, RASSF1A, and RARB, whose diagnostic potential was also validated in plasma samples with a sensitivity of 73% and a specificity of 82% [60].